Common Rheumatoid Arthritis Drugs May Increase Risk for Herpes Zoster
Common rheumatoid arthritis drugs methotrexate and biologics, but not prednisolone, may increase the risk for herpes zoster.
Common rheumatoid arthritis drugs methotrexate and biologics, but not prednisolone, may increase the risk for herpes zoster.
Muscle magnetic resonance imaging may complement a physician’s objective assessment in juvenile dermatomyositis, although negative MRI findings should not preclude treatment continuation.
Transcranial random noise stimulation improved both physical and cognitive symptoms in fibromyalgia.
Anthony Mariano, PhD, gives insight into dealing with patients’ demands for opioids.
An interview with Penney Cowan, founder and chief executive officer of the American Chronic Pain Association, where she discusses the ACPA’s publication aimed at helping healthcare practitioners improve care of patients with chronic pain.
The National Academies of Sciences, Engineering, and Medicine has released a report on cannabis and cannabinoids, outlining current knowledge and giving recommendations for future research.
Identifiable, distinct phases exist during the process of pain development after destabilization of the medial meniscus.
Drug development faces 2 major issues: pre-clinical animal efficacy studies do not accurately predict human efficacy, and clinical trials often wrongly fail to show drug efficacy.
Knee OA was associated with cortical thinning in brain regions not typically associated with pain processing.
Concern was expressed by some pain specialists over the new CDC guidelines addressing the opioid epidemic.